What is the recommended dosing of diphenhydramine (Benadryl) for adults, children, infants, and elderly patients, including oral and intramuscular/intravenous routes?

Diphenhydramine (Benadryl) Dosing

For parenteral diphenhydramine, use 1-2 mg/kg per dose (maximum 50 mg) administered intramuscularly or intravenously at a rate not exceeding 25 mg/min, primarily as second-line therapy in anaphylaxis after epinephrine. 1

Parenteral Dosing (IM/IV)

Pediatric Patients (excluding premature infants and neonates)

• Weight-based dosing: 1-2 mg/kg per dose 1
• Maximum single dose: 50 mg 1, 2, 3
• Daily dosing: 5 mg/kg/24 hours or 150 mg/m²/24 hours, divided into four doses 4
• Maximum daily dose: 300 mg 4
• Route: Deep intramuscular or intravenous at a rate generally not exceeding 25 mg/min 4

Adults

• Standard dose: 10-50 mg per dose 4
• Maximum single dose: 100 mg if required 4
• Maximum daily dose: 400 mg 4
• Route: Deep intramuscular or intravenous at a rate generally not exceeding 25 mg/min 4

Oral Dosing

Pediatric Patients

• Weight-based: 1-2 mg/kg per dose 2, 3
• Maximum single dose: 50 mg 2, 3
• Note: Oral liquid formulations are more readily absorbed than tablets 2, 3

Adults

• Standard dose: 25-50 mg per dose 1
• For insomnia: 50 mg at bedtime 5

Critical Clinical Context

Role in Anaphylaxis Management

Diphenhydramine is strictly second-line therapy to epinephrine and should never be administered alone in anaphylaxis. 1 The combination of diphenhydramine with an H2 antihistamine (ranitidine 1 mg/kg in children, 50 mg in adults) is superior to diphenhydramine alone in anaphylaxis management. 1

Important Safety Considerations

Cardiovascular risks: Intravenous diphenhydramine carries significant risk, particularly in infants and patients with cardiac disease. A case report documented cardiac arrest in a 3-month-old infant following a single 1.25 mg/kg IV dose. 6 The FDA label emphasizes that IV administration should not exceed 25 mg/min to minimize cardiovascular complications. 4

Toxicity threshold: Children under 6 years who ingest ≥7.5 mg/kg should be referred to an emergency department. 7 For patients 6 years and older, referral is warranted at ≥7.5 mg/kg or 300 mg (whichever is less). 7

Cognitive effects: First-generation antihistamines like diphenhydramine cause sedation and cognitive decline, particularly concerning in elderly patients due to anticholinergic effects. 8 Recent expert opinion suggests diphenhydramine should be phased out in favor of second-generation antihistamines with superior safety profiles. 9

Discharge Therapy Post-Anaphylaxis

For patients discharged after anaphylaxis, consider diphenhydramine every 6 hours for 2-3 days, though alternative dosing with non-sedating second-generation antihistamines is preferred. 2, 3

Contraindications and Precautions

• Premature infants and neonates: Parenteral formulation is not indicated 4
• Cardiac patients: Use extreme caution with IV administration 6
• Elderly patients: Increased risk of cognitive impairment and anticholinergic effects 8
• Never use for acute sedation in infants with congenital heart disease 6